Technology Seattle gene therapy biotech startup Immusoft raises $4.5M
Is wood the way to rebuild West Seattle Bridge? Architect shares idea to replace cracking roadway
West Seattle residents faced with a years-long traffic nightmare caused by the cracking and closed West Seattle Bridge may want to embrace the dream of a new bridge constructed in part with wood. © Provided by Geekwire B+H Architects’ in Seattle offered up renderings of a new West Seattle High-Rise Bridge made of mass timber and steel. (B+H Architects) The West Seattle High-Rise Bridge opened in 1984 and is the city’s most used bridge, carrying an average of over 100,000 vehicles a day, according to the City of Seattle.
Seattle-based biotech startupraised another $4.5 million and landed a $467,000 NIH grant to help further development of its drugs that treat genetic diseases.
Founded in 2009, Immusoft develops immune cell technology that uses blood cells from a patient to create therapeutic proteins targeted to treat diseases. Its lead candidate, ISP-001, treats Mucopolysaccharidosis type I, or MPS I, and has both orphan drug and rare pediatric disease designations from the FDA.
Seattle police chief to resign after vote to cut $4 million in budget, 100 officers
Carmen Best announced she would be retiring after the city council approved cutting nearly $4 million from the budget and reducing 100 officers.Best said she will retire on Sept. 2 after more than 28 years on the force in a letter to the department which was also published by the Seattle Times. Seattle Mayor Jenny Durkan, who picked Best to lead the department in 2018, appointed Deputy Chief Adrian Diaz as the interim chief, KING-TV reported.
Investors in the new round include previous backers Ikarian Capital, Mesa Verde Venture Partners, and Breakout Ventures.
The 12-person company last yeara $20 million Series B round.
, a veteran biotech executive, leads the company as CEO. In 2018 he replaced founder . Ainsworth previously founded gene therapy company RetroSense Therapeutics, which sold to Allergan in 2016 in a deal worth up to $555 million.
Storm sweep Aces to claim fourth WNBA title .
Storm sweep Aces to claim fourth WNBA titleThe Aces held an early nine-point lead but that vanished quickly as Finals MVP Breanna Stewart took control to score 26 points and Sue Bird, who won her first title 16 years ago, showed off her mastery of the no-look pass to dish out seven assists.